Urinary 2-hydroxyestrone/16α-hydroxyestrone ratio and risk of breast cancer in postmenopausal women

Journal of the National Cancer Institute

Volumn 91, Issue 12, 1999, Pages 1067-1072

  Ursin, Giske ^a   London, Stephanie ^b   Stanczyk, Frank Z ^c   Gentzschein, Elisabet ^c   Paganini Hill, Annlia ^a   Ross, Ronald K ^a   Pike, Malcolm C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c MS #44 ^*

Author keywords

[No Author keywords available]

Indexed keywords

16ALPHA HYDROXYESTRONE; 2 HYDROXYESTRONE; ESTRADIOL; ESTRIOL; ESTRONE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTROGEN METABOLISM; ESTROGEN URINE LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 0033575072     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.12.1067     Document Type: Article

References (53)

1. Henderson BE, Ross R, Bernstein L. Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture. Cancer Res 1988;48:246-53.
2. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993;15:36-47.
3. Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 1993; 15:48-65.
4. Adlercreutz H, Fotsis T, Hockerstedt K, Hamalainen E, Bannwart C, Bloigu S, et al. Diet and urinary estrogen profile in premenopausal omnivorous and vegetarian women and in premenopausal women with breast cancer. J Steroid Biochem 1989;34:527-30.
5. Clark JH, Paszko Z, Peck EJ Jr. Nuclear binding and retention of the receptor estrogen complex: relation to the agonistic and antagonistic properties of estriol. Endocrinology 1977;100: 91-6.
6. Fishman J, Martucci C. Biological properties of 16 alpha-hydroxyestrone: implications in estrogen physiology and pathophysiology. J Clin Endocrinol Metab 1980;51:611-5.
7. Martucci C, Fishman J. Direction of estradiol metabolism as a control of its hormonal action-uterotrophic activity of estradiol metabolites. Endocrinology 1977;101:1709-15.
8. Liehr JG, Ulubelen AA, Strobel HW. Cytochrome P-450-mediated redox cycling of estrogens. J Biol Chem 1986;261:16865-70.
9. Lemon HM, Heidel JW, Rodriguez-Sierra JF. Increased catechol estrogen metabolism as a risk factor for nonfamilial breast cancer. Cancer 1992;69:457-65.
10. Yager JD, Liehr JG. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 1996;36:203-32.
11. Bradlow HL, Telang NT, Sepkovic DW, Osborne MP. 2-Hydroxyestrone: the "good" estrogen. J Endocrinol 1996;150 Suppl: S259-65.
12. Bradlow HL, Hershcopf RE, Fishman JF. Oestradiol 16 alpha-hydroxylase: a risk marker for breast cancer. Cancer Surv 1986;5:573-83.
13. Bradlow HL, Hershcopf R, Martucci C, Fishman J. 16α-Hydroxylation of estradiol: a possible risk marker for breast cancer. Ann N Y Acad Sei 1986;464:138-51.
14. Bradlow HL, Hershcopf RJ, Martucci CP, Fishman J. Estradiol 16 alpha-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans. Proc Natl Acad Sei U S A 1985;82:6295-9.
15. Schneider J, Kinne D, Fracchia A, Pierce V, Anderson KE, Bradlow HL, et al. Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc Natl Acad Sci U S A 1982;79:3047-51.
16. Osborne MP, Karmali RA, Hershcopf RJ, Bradlow HL, Kourides IA, Williams WR, et al. Omega-3 fatty acids: modulation of estrogen metabolism and potential for breast cancer prevention. Cancer Invest 1988;8:629-31.
17. Kabat GC, Chang CJ, Sparano JA, Sepkovic DW, Hu XP, Khalil A, et al. Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol Biomarkers Prev 1997;6:505-9.
18. Meilahn EN, De Stavola B, Allen DS, Fentiman I, Bradlow HL, Sepkovic DW, et al. Do urinary oestrogen metabolites predict cancer? The Guernsey III cohort follow-up. Br J Cancer 1998;78:1250-5.
19. Ursin G, London S, Stanczyk FZ. Gentzschein E, Paganini-Hill A, Ross RK, et al. A pilot study of urinary estrogen metabolites (16α-OHEI and 2-OHEI) in postmenopausal women with and without breast cancer. Environ Health Perspect 1997;105(Suppl 3):601-5.
20. Longnecker MP, Paganini-Hill A, Ross RK. Lifetime alcohol consumption and breast cancer risk among postmenopausal women in Los Angeles. Cancer Epidemiol Biomarkers Prev 1995;4:721-5.
21. Seiffert JE, editor. SEER Program: comparative staging guide for cancer. Major cancer sites. Version 1.1. Bethesda (MD): National Institutes of Health, National Cancer Institute; 1993 Report No. (NIH)93-3640.
22. Fishman J, Hellman L, Zumoff B, Gallagher TF. Influence of thyroid hormone on estrogen metabolism in man. J Clin Endocrinol Metab 1962;22:389-92.
23. Galbraith RA, Michnovicz JJ. The effects of cimetidine on the oxidative metabolism of estradiol. N Engl J Med 1989;321:269-74.
24. Osborne MP, Telang NT, Kaur S, Bradlow HL. Influence of chemopreventive agents on estradiol metabolism and mammary preneoplasia in the C3H mouse. Steroids 1990;55:114-9.
25. Niwa T, Bradlow HL, Fishman J, Swaneck GE. Induction and inhibition of estradiol hydroxylase activities in MCF-7 human breast cancer cells in culture. Steroids 1990;55: 297-302.
26. Willett WC, Stampfer MJ, Underwood BA, Speizer FE, Rosner B, Hennekens CH. Validation of a dietary questionnaire with plasma carotenoid and alpha-tocopherol levels. Am J Clin Nutr 1983;38:631-9.
27. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985;122: 51-65.
28. Klug TL, Bradlow HL, Sepkovic DW. Monoclonal antibody-based enzyme immunoassay for simultaneous quantitation of 2- and 16α-hydroxyestrone in urine. Steroids 1994;59: 648-55.
29. Ziegler RG, Rossi SC, Fears TR, Bradlow HL, Adlercreutz H, Sepkovic D, et al. Quantifying estrogen metabolism: an evaluation of the reproducibility and validity of enzyme immunoassay s for 2-hydroxyestrone and 16alpha-hydroxyestrone in urine. Environ Health Perspect 1997;105(suppl):607-14.
30. Katagiri H, Stanczyk FZ, Goebelsmann U. Estriol in pregnancy. III. Development, comparison and use of specific antisera for rapid radioimmunoassay of unconjugated estriol in pregnancy plasma. Steroids 1974;24:225-38.
31. Stanczyk FZ, Shoupe D, Nunez V, Macias-Gonzales P, Vijod MA, Lobo RA. A randomized comparison of nonoral estradiol delivery in postmenopausal women. Am J Obstet Gynecol 1988;159:1540-6.
32. Cassidenti DL, Vijod AG, Vijod MA, Stanczyk FZ, Lobo RA. Short-term effects of smoking on the pharmakokinetic profiles of micronized estradiol in postmenopausal women. Am J Obstet Gynecol 1990;163:1953-60.
33. Breslow NE, Day NE. Statistical methods in cancer research. Volume 1 - The analysis of case-control studies. IARC Sci Publ 1980;32: 5-338.
34. Henderson BE, Gordon RJ, Menck H, Soohoo J, Martin SP, Pike MC. Lung cancer and air pollution in southcentral Los Angeles county. Am J Epidemiol 1975;101:477-89.
35. Persson BH, Risholm L. Oophorectomy and cortisone treatment as a method of eliminating estrogen production in patients with breast cancer. Acta Endocrinol 1964;47:15-26.
36. Marmorston J, Crowley LG, Myers SM, Stern E, Hopkins CE. II. Urinary excretion of estrone, estradiol, and estriol by patients with breast cancer and benign breast disease. Am J Obstet Gynecol 1965;92:460-7.
37. Arguelles AE. Poggi UL, Saborida C, Hoffman C, Chekherdemian M, Blanchard O. Endocrine profiles and breast cancer. Lancet 1973;1: 165-8.
38. Gronroos M, Aho AJ. Estrogen metabolism in postmenopausal women with primary and recurrent breast cancer. Eur J Cancer 1968;4: 523-7.
39. Grattarola R, Secreto G, Recchione C, Castellini W. Androgens in breast cancer. II. Endometrial adenocarcinoma and breast cancer in married postmenopausal women. Am J Obstet Gynecol 1974;118:173-8.
40. Thijssen JH, Poortman J, Schwarz F. Androgens in postmenopausal breast cancer; excretion, production and interaction with estrogens. J Steroid Biochem 1975;6:729-34.
41. Morreal CE, Dao TL, Nemoto T, Lonergan PA. Urinary excretion of estrone, estradiol, and estriol in postmenopausal women with primary breast cancer. J Natl Cancer Inst 1979;63: 1171-4.
42. Bernstein L, Ross RK, Pike MC, Brown JB, Henderson BE. Hormone levels in older women: a study of post-menopausal breast cancer patients and healthy population controls. Br J Cancer 1990;61:298-302.
43. Adlercreutz H, Gorbach SL, Goldin BR, Woods MN, Dwyer JT, Hamalainen E. Estrogen metabolism and excretion in Oriental and Caucasian women. J Natl Cancer Inst 1994;86: 1076-82.
44. Schneider J, Bradlow LH, Strain G, Levin J, Anderson K, Fishman J. Effects of obesity on estradiol metabolism: decreased formation of nonuterotropic metabolites. J Clin Endocrinol Metab 1982;56:973-8.
45. Hoffman AR. Majchrowicz E, Poth MA, Paul SM. Ethanol reduces hepatic estrogen-2-hydroxylase activity in the male rat. Life Sci 1981;29:789-94.
46. Schneider J, Huh MM, Bradlow HL, Fishman J. Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J Biol Chem 1984;259:4840-5.
47. Telang NT, Suto A, Wong GY, Osborne MP, Bradlow HL. Induction by estrogen metabolite 16 alpha hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst 1992;84: 634-8.
48. Li JJ, Li SA, Oberley TD, Parsons JA. Carcinogenic activities of various steroidal and nonsteroidal estrogens in the hamster kidney: relation to hormonal activity and cell proliferation. Cancer Res 1995;55:4347-51.
49. Osborne MP, Bradlow HL, Wong GY, Telang NT. Upregulation of estradiol C16α-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk. J Natl Cancer Inst 1993;85:1917-20.
50. Lottering ML, Haag M, Seegers JC. Effects of 17β-estradiol metabolites on cell cycle events in MCF-7 cells. Cancer Res 1992;52:5926-32.
51. Musey PI, Collins DC, Bradlow HL, Gould KG, Preedy JR. Effect of diet on oxidation of 17β-estradiol in vivo. J Clin Endocrinol Metab 1987;65:792-5.
52. Longcope C, Gorbach S, Goldin B, Woods M, Dwyer J, Morrill A, et al. The effect of a low fat diet on estrogen metabolism. J Clin Endocrinol Metab 1987;64:1246-50.
53. Michnovicz JJ, Bradlow HL. Altered estrogen metabolism and excretion in humans following consumption of indole-3-carbinol. Nutr Cancer 1991;16:59-66.